Literature DB >> 11951126

The majority of cutaneous squamous cell carcinomas arise in actinic keratoses.

D Czarnecki1, C J Meehan, F Bruce, G Culjak.   

Abstract

BACKGROUND: Retrospective studies have given conflicting results with respect to how many cutaneous squamous cell carcinomas (SCCs) arise in actinic keratoses (AK).
OBJECTIVE: This study was conducted to determine what percentage of SCCs arise in AKs and to obtain more information about two histological features of SCCs, namely, thickness and ulceration.
METHODS: A prospective study was done of all SCCs treated by the authors during one calendar year.
RESULTS: Two hundred eight patients with SCC were entered into the study. An AK was contiguous with an SCC in 72% of the cases. This was taken as evidence that the SCC arose in the AK. Men presented with thicker and more ulcerated SCCs than women, but these were not statistically significant: p = 0.06 for thickness and p = 0.07 for ulceration. Ulcerated SCCs were more likely to arise on the head and neck (p = 0.02), on patients who had multiple skin cancers (p = 0.005), and on patients who had a family history of skin cancer (p = 0.03).
CONCLUSION: Actinic keratoses need to be removed before they turn into SCCs. The prognostic significance of ulceration of cutaneous SCCs needs to be determined.

Entities:  

Mesh:

Year:  2002        PMID: 11951126     DOI: 10.1007/s10227-001-0041-x

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN: 1203-4754            Impact factor:   2.092


  25 in total

1.  Curcuminoids activate p38 MAP kinases and promote UVB-dependent signalling in keratinocytes.

Authors:  Elias E Ayli; Susanne Dugas-Breit; Weijie Li; Christine Marshall; Liang Zhao; Marc Meulener; Thomas Griffin; Joel M Gelfand; John T Seykora
Journal:  Exp Dermatol       Date:  2010-04-20       Impact factor: 3.960

2.  Actinic keratosis treatment as a key component of preventive strategies for nonmelanoma skin cancer.

Authors:  Joel L Cohen
Journal:  J Clin Aesthet Dermatol       Date:  2010-06

3.  Oral capecitabine plus subcutaneous interferon alpha in advanced squamous cell carcinoma of the skin.

Authors:  Uwe Wollina; Gesina Hansel; Andreas Koch; Erich Köstler
Journal:  J Cancer Res Clin Oncol       Date:  2004-12-24       Impact factor: 4.553

4.  Tolerability of Ingenol Mebutate Gel, 0.05%, for Treating Patients with Actinic Keratosis on the Scalp in a Community Dermatology Practice.

Authors:  Miriam S Bettencourt
Journal:  J Clin Aesthet Dermatol       Date:  2016-03-01

5.  Comparison of "Lesion-by-Lesion" and Field Photodynamic Therapy in the Prevention of Actinic Keratoses: A Randomized, Split-Face, Single-Blind Pilot Study.

Authors:  Inge Seubring; Joannes M M Groenewoud; Marie-Jeanne P Gerritsen
Journal:  Dermatology       Date:  2017-01-18       Impact factor: 5.366

6.  Correlation of telomere length to malignancy potential in non-melanoma skin cancers.

Authors:  Hanae Yamada-Hishida; Yoshimasa Nobeyama; Hidemi Nakagawa
Journal:  Oncol Lett       Date:  2017-10-26       Impact factor: 2.967

7.  Single Ablative Fractional Resurfacing Laser Treatment For Forearm Actinic Keratoses: 6-Month Follow-Up Data From An Intrapatient Comparison Between Treated and Untreated Sites.

Authors:  Roy Chen; Jeffrey J Wargo; Amy Williams; Elizabeth Cates; Dan F Spandau; Christina Knisely; Jeffrey B Travers
Journal:  Lasers Surg Med       Date:  2019-11-17       Impact factor: 4.025

8.  Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53.

Authors:  Liang Zhao; Weijie Li; Christine Marshall; Thomas Griffin; Matthew Hanson; Ryan Hick; Tzvete Dentchev; Erik Williams; Adrienne Werth; Christopher Miller; Hasan Bashir; Warren Pear; John T Seykora
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

9.  Clinicopathological study of 21 cases of eyelid actinic keratosis.

Authors:  Elena López-Tizón; Enrique Mencía-Gutiérrez; María Garrido-Ruíz; Esperanza Gutiérrez-Díaz; Fernando López-Ríos
Journal:  Int Ophthalmol       Date:  2008-07-17       Impact factor: 2.031

10.  In-office Painless Aminolevulinic Acid Photodynamic Therapy: A Proof of Concept Study and Clinical Experience in More Than 100 Patients.

Authors:  George M Martin
Journal:  J Clin Aesthet Dermatol       Date:  2016-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.